Video | Investor Briefing | PHASE Scientific Agreement
16 July 2025
Lumos held an investor briefing outlining the transformational US$317 million distribution agreement with PHASE Scientific.
We are inviting qualified B2B Service inquiries for those seeking to develop point-of-care reader technology
By entering your email address you are agreeing to our Privacy Policy.
Innovation at the point-of-care
2024 Lumos Diagnostics